Belite Bio, Inc

NASDAQ:BLTE

64.51 (USD) • At close August 28, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20242023202220212020
Revenue 00000
Cost of Revenue 0.4490.3990.1980.030.017
Gross Profit -0.449-0.399-0.198-0.03-0.017
Gross Profit Ratio 00000
Reseach & Development Expenses 29.93924.8448.8697.4193.688
General & Administrative Expenses 10.0576.8243.9522.3782.055
Selling & Marketing Expenses 00000
SG&A 10.0576.8243.9522.3782.055
Other Expenses -0.449-0.399000
Operating Expenses 39.54731.26912.8219.7975.743
Operating Income -39.996-31.668-12.821-9.797-5.743
Operating Income Ratio 00000
Total Other Income Expenses Net 3.8580.0450.1730.131-0.009
Income Before Tax -36.138-31.623-12.648-9.666-5.752
Income Before Tax Ratio 00000
Income Tax Expense 0.0060.009000.001
Net Income -36.144-31.632-12.648-9.666-5.753
Net Income Ratio 00000
EPS -1.18-1.19-0.63-0.4-0.62
EPS Diluted -1.18-1.19-0.63-0.4-0.62
EBITDA -35.669-31.529-12.434-9.636-5.714
EBITDA Ratio 00000